Washington Industry Journal
SEE OTHER BRANDS

Top industries and services news from Washington state

Washington Industry Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Washington Industry Journal.

Press releases published on June 17, 2025

The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial

The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial

The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial REDMOND, WA, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- FOR IMMEDIATE RELEASE Contact: Dellann Elliott Mydland, …

TDG Gold Announces Acquisition of Anyox Copper and C$25 Million Bought Deal Private Placement

TDG Gold Announces Acquisition of Anyox Copper and C$25 Million Bought Deal Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WHITE ROCK, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- TDG Gold Corp (TSXV: TDG, OTCQX:TDGGF) (the “Company” or “TDG”) is pleased to announce that it …

Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide

Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide

BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that …

Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS

Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS

CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to zagociguat for the treatment of MELAS (Mitochondrial Encephalomyopathy, Lactic …

Where Innovation Gets Funded: Investor Experience and Pitchfest Return to HR Tech 2025

Where Innovation Gets Funded: Investor Experience and Pitchfest Return to HR Tech 2025

WEST PALM BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Dedicated to delivering actionable, memorable opportunities to its community, HR Tech today shared details of this year’s Investor Experience and Pitchfest competition, which will take place …

Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics

Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics

IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced its collaboration with Aerora, a provider of integrated NDAA-compliant …

Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty …

Sonoco Names Paul Joachimczyk Chief Financial Officer

Sonoco Names Paul Joachimczyk Chief Financial Officer

HARTSVILLE, S.C., June 17, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (NYSE: SON), a global leader in value-added sustainable packaging, today announced that Paul Joachimczyk has been named Chief Financial Officer, effective June 30, 2025. “We are …

SRQ Resources start drilling at Target 900, Lac Brulé property

SRQ Resources start drilling at Target 900, Lac Brulé property

MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- SRQ Resources Inc. (“SRQ” or the “Company”) (TSX-V: SRQ) is pleased to announce the mobilization of drilling crews and the commencement of its 4,000-metre diamond drilling program at the highly prospective Target …

Aldebaran Reports Infill Drilling Results from Eleven Holes at the Altar Copper-Gold Project in San Juan Argentina

Aldebaran Reports Infill Drilling Results from Eleven Holes at the Altar Copper-Gold Project in San Juan Argentina

VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Aldebaran Resources Inc. (“Aldebaran” or the “Company”) (TSX-V: ALDE, OTCQX: ADBRF) is pleased to provide results of 11 holes from the in-fill drilling program currently being completed at the …

Regenx Tech Provides Operational Update

Regenx Tech Provides Operational Update

EDMONTON, Alberta, June 17, 2025 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) is providing an update on the status of the restart of operations at its new facility in Newport, Tennessee …

DAVIDsTEA Delivers Strong Start to Fiscal 2025 with Higher Margins and Profitability Gains in Q1

DAVIDsTEA Delivers Strong Start to Fiscal 2025 with Higher Margins and Profitability Gains in Q1

Q1 sales reached $13.5 million, representing a 0.6% increase year-over-year Gross profit margin rose to 51.1%, up from 43.3% in Q1 2024 Net loss significantly reduced to $0.2 million compared to $2.6 million in Q1 2024 Adjusted EBITDA turned positive at $1 …

DAVIDsTEA démarre l'exercice 2025 en force avec des marges plus élevées et des gains de rentabilité au T1

DAVIDsTEA démarre l'exercice 2025 en force avec des marges plus élevées et des gains de rentabilité au T1

Au T1, les ventes ont atteint 13,5 M$, soit une augmentation de 0,6 % en glissement annuel. La marge brute a augmenté pour atteindre 51,1 %, contre 43,3 % au T1 2024. La perte nette a été considérablement réduite pour atteindre 0,2 M$, contre 2,6 M$ au T1 …

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone

MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the final assay results from the Southwest Zone (“Southwest”) as part of its ongoing 2025 Exploration …

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest

MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer les résultats d’analyse finaux provenant de la zone Southwest («Southwest») dans le cadre de sa …

Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia

Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia

Highlights Metallurgical testwork program with encouraging preliminary results including 89% average flotation recovery from 120-150µm grind size producing clean concentrate with grade of 20-25% Cu. Pre-concentration and heap leach testwork ongoing with …

Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease

Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease

The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for neurodegenerative diseases VTX3232 …

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting

- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of …

Material Update on Off-Market Takeover by Bastion Mining

Material Update on Off-Market Takeover by Bastion Mining

TORONTO, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) to acquire …

Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project

Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project

Locked cycle tests exceed 90% copper and molybdenum recoveries and confirm clean final products with high separation efficiency Vancouver, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service